ONCOTELIC ANNOUNCES THAT ORF8 MUTATIONS ARE DRIVING THE EVOLUTION OF THE DELTA AND THE OMICRON VARIANTS.
Retrieved on:
Wednesday, December 22, 2021
Pancreatic cancer, Mutation, RNA, Genome, Entropy, Communication, Publication, Investigations into the origin of COVID-19, Patient, Private Securities Litigation Reform Act, Cancer, Cocaine, CEO, AML, Form 10-K, MedRxiv, Optimism, Acquisition, New, Serum, SEC, Survival, Therapy, Forward-looking statement, COVID-19, DIPG, Treatment, CA4P, Tree, Oxigen Services, Intelligence, Company, F120, Safety, Severe acute respiratory syndrome coronavirus 2, Annual report, CLIN, Risk, Melanoma, Radio spectrum, Glioma, GLOBE, Virology, Pharmaceutical industry, TGF, Omicron, Delta, Artemisinin, COVID
The analysis allows us to position our therapeutic and vaccine platform against ORF8 to address this pandemic as it further mutates.
Key Points:
- The analysis allows us to position our therapeutic and vaccine platform against ORF8 to address this pandemic as it further mutates.
- ORF8 and the evolution of the Delta and Omicron variants.
- Further mutations of these two residues are creating new lineage trees that are offshoots from the Delta backbone.
- More importantly the further mutational expansion of the S-protein in the emerging Omicron variant is now followed with the acquisition of ORF8 mutations 119 and 120.